세계의 환각제 시장 : 약물 유형별, 용도별, 유통 채널별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율, 예측(2023-2030년)

Psychedelic Drugs Market, by Drug Type, By Application, By Distribution Channel, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030

US $ 3,250 ￦ 4,592,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.

US $ 4,650 ￦ 6,570,000

PDF (5 User License)

PDF 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 5,650 ￦ 7,983,000

PDF & Excel (Enterprise User License)

PDF & Excel 보고서를 동일 기업 내 모든 사용자가 사용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

보고서 하이라이트

환각제(Psychedelic Drugs) 시장 규모는 2022년 48억 7,012만 달러였으며, 2023년부터 2030년까지의 CAGR은 13.46%로 추이하며 성장할 것으로 예상됩니다.

이러한 화학 물질은 잠재적인 치료 및 정신적 응용으로 과학계의 주목을 받고 있지만, 그 사용에는 내재된 위험이 따릅니다. 이러한 위험에는 이러한 물질을 사용할 때 개인이 겪을 수 있는 부작용과 심리적 어려움이 포함됩니다.

환각제 시장 - 시장 역학 :

• 정신 건강 문제 해결의 중요성에 대한 인식 증가
• 이 시장의 성장은 도시 혼잡과 교통 비효율 문제를 해결하는 솔루션에 대한 수요에 의해 크게 형성되었습니다. 신흥 기술과 혁신적인 모빌리티 솔루션은 교통 혼잡을 완화하고 환경에 미치는 영향을 줄이기 위한 새로운 접근 방식을 제공하면서 도시 교통 환경을 재정의하는 데 중추적인 역할을 하고 있습니다. 예측 기간 동안 지속 가능한 도시 모빌리티를 촉진하는 정부 이니셔티브, 공공-민간 협력 및 옹호 캠페인이 시장 확대를 주도할 것으로 예상됩니다.
• 예를 들어, 최근 수십 년 동안 Urban Mobility Foundation과 같은 조직은 도시 교통 패러다임을 변화시키기 위한 이니셔티브를 주도해 왔습니다. 이러한 노력은 지속 가능한 모빌리티 관행의 개발과 채택으로 이어져 보다 효율적이고 친환경적인 도시 통근 옵션에 기여하고 있습니다.

환각제 시장-세분화 분석 :

• 환각제 시장은 약물 유형, 용도, 유통 채널, 지역 등을 주요 분류로 하는 종합적인 세분화 구조를 보여줍니다.
• 약물 유형의 분류에는 케타민, 감마 히드록시부티르산(GHB), 리젤르산 디에틸아미드(LSD), 실로시빈, 3,4-메틸에네디옥시메탄페타민 및 기타 다양한 약물 유형과 같은 다양한 카테고리가 있습니다. 주목해야할 것은 시장 상황이 현재 실로시빈에 지배되고 있다는 것입니다. 이 특정 화합물은 임상 연구의 최전선에 있으며, 중독, 불안, 우울증, 종말기의 고통 등 다양한 증상 치료에 잠재적 효능에 초점을 맞춘 연구가 진행되고 있습니다. 예비적인 조사 결과로부터 유망한 결과가 밝혀지고, 실로시빈에 근거한 치료법의 개발에 큰 관심과 자금 원조가 모여 있습니다.

환각제 시장-경쟁 구도 :

기업은 기업 웹사이트, 온라인 리테일 플랫폼, 오프라인 리테일러, 유통 파트너, 소비자 직접 판매 모델 등 다양한 유통 채널을 활용하여 제품을 시장에 출시하기 위해 다양한 전략을 사용합니다. 제품 제조업체는 가격 전략, 제품 성능, 제조 기술, 기술 혁신, 브랜드 평판, 제품 가용성 등 여러 측면에서 경쟁에 참여합니다.

시장 입지를 강화하고 시장 점유율을 확대하기 위해 기업들은 다양한 전략을 사용합니다. 여기에는 신제품 출시를 통한 제품 포트폴리오 강화, 유통망 확장, 연구 개발 투자 확대, 인수합병 참여 등이 포함됩니다.

예를 들어, 2022년 10월에는 증거 기반의 안전한 환각제 보조 치료법을 발전시키는 데 전념하는 정신 건강 관리 기관인 Numinus Wellness Inc.가 중증 및 만성 질환을 위한 케타민 프로그램을 도입했습니다. 이 혁신적인 이니셔티브는 브리티시 컬럼비아, 유타, 퀘벡에 위치한 누미너스 클리닉에서 우선적으로 시행될 예정이며, 새로운 치료 방법을 통해 의료 질환을 해결하기 위한 진보적인 접근 방식을 의미합니다.

목차

제1장 환각제 시장 개요

• 조사 범위
• 시장 추정 연도

제2장 주요 요약

• 시장 분석
• 경쟁 인사이트

제3장 환각제-주요 시장 동향

• 시장 성장 촉진 요인
• 시장 성장 억제 요인
• 시장 기회
• 향후 시장 동향

제4장 환각제-산업 연구 조사

• PEST 분석
• Porter's Five Forces 분석
• 성장 전망 맵핑
• 규제 프레임워크 분석

제5장 환각제 시장 : COVID-19 영향 분석

• COVID-19 이전 영향 분석
• COVID-19 이후 영향 분석

제6장 환각제 시장 상황

• 환각제 시장 점유율 분석(2022년)
• 주요 제조사별 분석 데이터
  • 기존 기업 분석
  • 신흥 기업 분석

제7장 환각제 시장-약물 유형별

• 개요
  • 약물 유형별 부문 점유율 분석
  • 케타민
  • 감마 하이드록시부티르산(GHB)
  • 리젤르산 디에틸아미드(LSD)
  • 실로시빈
  • 3,4-메틸렌디옥시메탄페타민
  • 기타 약물

제8장 환각제 시장-용도별

• 개요
  • 용도별 부문 점유율 분석
  • 아편 중독
  • 치료 저항성 우울증
  • 기면증
  • 외상 후 스트레스 장애
  • 공황 장애
  • 기타 용도

제9장 환각제 시장-유통 채널별

• 개요
  • 유통 채널별 부문 점유율 분석
  • 소매 약국
  • 병원 약국
  • 온라인 유통 채널

제10장 환각제 시장-지역별

• 소개
• 북미
  • 개요
  • 북미의 주요 제조사
  • 미국
  • 캐나다
• 유럽
  • 개요
  • 유럽의 주요 제조사
  • 독일
  • 이탈리아
  • 영국
  • 프랑스
  • 러시아
  • 네덜란드
  • 스웨덴
  • 폴란드
  • 기타
• 아시아 태평양(APAC)
  • 개요
  • 아시아 태평양의 주요 제조사
  • 인도
  • 중국
  • 일본
  • 한국
  • 호주
  • 태국
  • 인도네시아
  • 필리핀
  • 기타
• 남미
  • 개요
  • 남미의 주요 제조사
  • 브라질
  • 멕시코
  • 아르헨티나
  • 콜롬비아
  • 기타
• 중동 및 아프리카
  • 개요
  • 중동 및 아프리카의 주요 제조사
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 이스라엘
  • 터키
  • 알제리
  • 이집트
  • 기타

제11장 주요 벤더 분석-환각제 산업

• 경쟁 대시보드
• 기업 개요
  • Silo Wellness
  • Revive Therapeutics
  • PsyBio Therapeutics
  • Numinus Wellness
  • Mydecine Innovations Group
  • MindMed
  • MagicMed Industries
  • Field Trip Health
  • Entheon Biomedical
  • Eleusis Ltd.
  • Cybin Inc.
  • Compass Pathways
  • Bright Minds Biosciences
  • Beckley Psytech
  • Atai Life Sciences

제12장 애널리스트의 전방위 전망

LYJ

영문 목차

영문목차

REPORT HIGHLIGHT

Psychedelic Drugs Market size was valued at USD 4,870.12 Million in 2022, expanding at a CAGR of 13.46% from 2023 to 2030.

Substances categorized as "psychedelics" possess the capacity to induce profound alterations in perception, cognitive processes, and emotional states, often leading to intense sensory encounters and potentially life-altering insights. This category includes substances like psilocybin mushrooms, DMT (dimethyltryptamine), and LSD (lysergic acid diethylamide). These compounds exert their effects by targeting specific receptors in the brain, resulting in hallucinogenic phenomena, heightened emotional responses, and shifts in consciousness.

While these chemical agents have garnered scientific attention for their potential therapeutic and spiritual applications, their usage carries inherent risks. These hazards encompass adverse side effects and psychological challenges that individuals may encounter when engaging with these substances.

Psychedelic Drugs Market - Market Dynamics:

• Increasing awareness about the importance of addressing mental health concerns

• The growth of the market is significantly shaped by the demand for solutions addressing the challenges of urban congestion and transportation inefficiencies. Emerging technologies and innovative mobility solutions are playing a pivotal role in redefining urban transportation landscapes, offering novel approaches to alleviate traffic congestion and reduce environmental impact. Throughout the forecasted period, it is anticipated that government initiatives, public-private collaborations, and advocacy campaigns promoting sustainable urban mobility will drive market expansion.

• For example, in recent decades, organizations like the Urban Mobility Foundation have spearheaded initiatives aimed at transforming urban transportation paradigms. Their efforts have resulted in the development and adoption of sustainable mobility practices, contributing to more efficient and eco-friendly urban commuting options.

Psychedelic Drugs Market - Key Insights:

• As per the insights provided by our research analysts, the global Market for Psychedelic Drugs is poised to experience a robust annual growth rate, with a projected Compound Annual Growth Rate (CAGR) of approximately 14.2% throughout the forecast period spanning from 2023 to 2030.

• This industry's growth trajectory is underpinned by significant factors, primarily the increasing recognition of the critical need to address mental health challenges on a global scale.

• Within the realm of drug categorization, the segment dedicated to psilocybin emerged as the dominant player in terms of market share for the year 2022.

• Furthermore, when considering application segmentation, the category related to the treatment of resistant depression stood out as the frontrunner in 2022.

• Examining distribution channels, hospitals took the lead in 2022 in terms of market presence.

• In geographical terms, North America emerged as the primary revenue contributor in the year 2022.

Psychedelic Drugs Market- Segmentation Analysis:

• The Global Market for Psychedelic Drugs exhibits a comprehensive segmentation structure, incorporating Drug Type, Application, Technology, and Geographical Region as its key categorizations.

• Within the spectrum of Drug Type classification, the market presents a diverse array of categories, including Ketamine, Gamma Hydroxybutyric Acid (GHB), Lysergic Acid Diethylamide (LSD), Psilocybin, 3,4-MethylEnedioxyMethamphetamine, and various other drug types. Notably, the market's landscape is currently dominated by Psilocybin. This particular compound has been at the forefront of clinical investigations, with studies focusing on its potential efficacy in treating a spectrum of conditions such as addiction, anxiety, depression, and end-of-life distress. The preliminary research findings have unveiled promising outcomes, prompting considerable interest and financial support for the development of treatment modalities based on Psilocybin.

Psychedelic Drugs Market- Competitive Landscape:

Enterprises employ diverse strategies to bring their products to market, utilizing an array of distribution channels such as corporate websites, online retail platforms, brick-and-mortar retailers, distribution partners, and direct-to-consumer models. Product manufacturers engage in competition across multiple fronts, including pricing strategies, product performance, manufacturing techniques, technological innovation, brand reputation, and product availability.

To fortify their market presence and expand their market share, companies employ a range of tactics. These include product portfolio enhancements through new product launches, the expansion of distribution networks, increased investments in research and development, and participation in mergers and acquisitions.

For instance, in October 2022, Numinus Wellness Inc., a mental health care organization dedicated to advancing evidence-based, safe psychedelic-assisted treatments, introduced its Ketamine for Serious and Chronic Medical Illness Program. This innovative initiative is expected to roll out initially in Numinus clinics located in British Columbia, Utah, and Quebec, signifying a progressive approach to addressing medical conditions through novel therapeutic avenues.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PSYCHEDELIC DRUGS MARKET KEY PLAYERS

• Silo Wellness
• Revive Therapeutics
• PsyBio Therapeutics
• Numinus Wellness
• Mydecine Innovations Group
• MindMed
• MagicMed Industries
• Field Trip Health
• Entheon Biomedical
• Eleusis Ltd.
• Cybin Inc.
• Compass Pathways
• Bright Minds Biosciences
• Beckley Psytech
• Atai Life Sciences

GLOBAL PSYCHEDELIC DRUGS MARKET, BY DRUG TYPE

• Ketamine
• Gamma Hydroxybutyric Acid (GHB)
• Lysergic Acid Diethylamide (LSD)
• Psilocybin
• 3,4-MethylEnedioxyMethamphetamine
• Other Drug Types

GLOBAL PSYCHEDELIC DRUGS MARKET, BY APPLICATION

• Opiate Addiction
• Treatment-Resistant Depression
• Narcolepsy
• Post-traumatic Stress Disorder
• Panic Disorder
• Others Applications

GLOBAL PSYCHEDELIC DRUGS MARKET, BY DISTRIBUTION

• Retail Pharmacy
• Hospital Pharmacy
• Online Distribution Channel

GLOBAL PSYCHEDELIC DRUGS MARKET, BY REGION

• North America
  • The U.S.
  • Canada

• Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe

• Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC

• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM

• The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Psychedelic Drugs Market Overview

• 1.1. Study Scope
• 1.2. Market Estimation Years

2. Executive Summary

• 2.1. Market Snippet
  • 2.1.1. Psychedelic Drugs Market Snippet by Drug Type
  • 2.1.2. Psychedelic Drugs Market Snippet by Application
  • 2.1.3. Psychedelic Drugs Market Snippet by Distribution
  • 2.1.4. Psychedelic Drugs Market Snippet by Country
  • 2.1.5. Psychedelic Drugs Market Snippet by Region
• 2.2. Competitive Insights

3. Psychedelic Drugs Key Market Trends

• 3.1. Psychedelic Drugs Market Drivers
  • 3.1.1. Impact Analysis of Market Drivers
• 3.2. Psychedelic Drugs Market Restraints
  • 3.2.1. Impact Analysis of Market Restraints
• 3.3. Psychedelic Drugs Market Opportunities
• 3.4. Psychedelic Drugs Market Future Trends

4. Psychedelic Drugs Industry Study

• 4.1. PEST Analysis
• 4.2. Porter's Five Forces Analysis
• 4.3. Growth Prospect Mapping
• 4.4. Regulatory Framework Analysis

5. Psychedelic Drugs Market: COVID-19 Impact Analysis

• 5.1. Pre-COVID-19 Impact Analysis
• 5.2. Post-COVID-19 Impact Analysis
  • 5.2.1. Top Performing Segments
  • 5.2.2. Marginal Growth Segments
  • 5.2.3. Top Looser Segments
  • 5.2.4. Marginal Loss Segments

6. Psychedelic Drugs Market Landscape

• 6.1. Psychedelic Drugs Market Share Analysis, 2022
• 6.2. Breakdown Data, by Key Manufacturer
  • 6.2.1. Established Players' Analysis
  • 6.2.2. Emerging Players' Analysis

7. Psychedelic Drugs Market - By Drug Type

• 7.1. Overview
  • 7.1.1. Segment Share Analysis, By Drug Type, 2022 & 2030 (%)
  • 7.1.2. Ketamine
  • 7.1.3. Gamma Hydroxybutyric Acid (GHB)
  • 7.1.4. Lysergic Acid Diethylamide (LSD)
  • 7.1.5. Psilocybin
  • 7.1.6. 3,4-MethylEnedioxyMethamphetamine
  • 7.1.7. Other Drug Types

8. Psychedelic Drugs Market - By Application

• 8.1. Overview
  • 8.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
  • 8.1.2. Opiate Addiction
  • 8.1.3. Treatment-Resistant Depression
  • 8.1.4. Narcolepsy
  • 8.1.5. Post-traumatic Stress Disorder
  • 8.1.6. Panic Disorder
  • 8.1.7. Others Applications

9. Psychedelic Drugs Market - By Distribution

• 9.1. Overview
  • 9.1.1. Segment Share Analysis, By Distribution, 2022 & 2030 (%)
  • 9.1.2. Retail Pharmacy
  • 9.1.3. Hospital Pharmacy
  • 9.1.4. Online Distribution Channel

10. Psychedelic Drugs Market- By Geography

• 10.1. Introduction
  • 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
• 10.2. North America
  • 10.2.1. Overview
  • 10.2.2. Psychedelic Drugs Key Manufacturers in North America
  • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
  • 10.2.4. North America Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
  • 10.2.5. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.2.6. North America Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
  • 10.2.7. U.S.
    • 10.2.7.1. Overview
    • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.2.7.3. U.S. Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
    • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.2.7.5. U.S. Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
  • 10.2.8. Canada
    • 10.2.8.1. Overview
    • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.2.8.3. Canada Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
    • 10.2.8.4. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.2.8.5. Canada Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
• 10.3. Europe
  • 10.3.1. Overview
  • 10.3.2. Psychedelic Drugs Key Manufacturers in Europe
  • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
  • 10.3.4. Europe Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
  • 10.3.5. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.3.6. Europe Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
  • 10.3.7. Germany
    • 10.3.7.1. Overview
    • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.3.7.3. Germany Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
    • 10.3.7.4. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.7.5. Germany Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
  • 10.3.8. Italy
    • 10.3.8.1. Overview
    • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.3.8.3. Italy Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
    • 10.3.8.4. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.8.5. Italy Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
  • 10.3.9. United Kingdom
    • 10.3.9.1. Overview
    • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.3.9.3. United Kingdom Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
    • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.9.5. United Kingdom Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
  • 10.3.10. France
    • 10.3.10.1. Overview
    • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.3.10.3. France Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
    • 10.3.10.4. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.10.5. France Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
  • 10.3.11. Russia
    • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.3.11.2. Russia Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
    • 10.3.11.3. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.11.4. Russia Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
  • 10.3.12. Netherlands
    • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.3.12.2. Netherlands Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
    • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.12.4. Netherlands Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
  • 10.3.13. Sweden
    • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.3.13.2. Sweden Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
    • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.13.4. Sweden Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
  • 10.3.14. Poland
    • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.3.14.2. Poland Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
    • 10.3.14.3. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.14.4. Poland Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
  • 10.3.15. Rest of Europe
    • 10.3.15.1. Overview
    • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
    • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
• 10.4. Asia Pacific (APAC)
  • 10.4.1. Overview
  • 10.4.2. Psychedelic Drugs Key Manufacturers in Asia Pacific
  • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
  • 10.4.4. Asia Pacific Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
  • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.4.6. Asia Pacific Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
  • 10.4.7. India
    • 10.4.7.1. Overview
    • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.4.7.3. India Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
    • 10.4.7.4. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.7.5. India Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
  • 10.4.8. China
    • 10.4.8.1. Overview
    • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.4.8.3. China Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
    • 10.4.8.4. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.8.5. China Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
  • 10.4.9. Japan
    • 10.4.9.1. Overview
    • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.4.9.3. Japan Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
    • 10.4.9.4. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.9.5. Japan Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
  • 10.4.10. South Korea
    • 10.4.10.1. Overview
    • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.4.10.3. South Korea Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
    • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.10.5. South Korea Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
  • 10.4.11. Australia
    • 10.4.11.1. Overview
    • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.4.11.3. Australia Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
    • 10.4.11.4. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.11.5. Australia Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
  • 10.4.12. Thailand
    • 10.4.12.1. Overview
    • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.4.12.3. Thailand Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
    • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.12.5. Thailand Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
  • 10.4.13. Indonesia
    • 10.4.13.1. Overview
    • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.4.13.3. Indonesia Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
    • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.13.5. Indonesia Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
  • 10.4.14. Philippines
    • 10.4.14.1. Overview
    • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.4.14.3. Philippines Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
    • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.14.5. Philippines Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
  • 10.4.15. Rest of APAC
    • 10.4.15.1. Overview
    • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.4.15.3. Rest of APAC Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
    • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.15.5. Rest of APAC Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
• 10.5. Latin America
  • 10.5.1. Overview
  • 10.5.2. Psychedelic Drugs Key Manufacturers in Latin America
  • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
  • 10.5.4. Latin America Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
  • 10.5.5. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.5.6. Latin America Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
  • 10.5.7. Brazil
    • 10.5.7.1. Overview
    • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.5.7.3. Brazil Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
    • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.7.5. Brazil Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
  • 10.5.8. Mexico
    • 10.5.8.1. Overview
    • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.5.8.3. Mexico Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
    • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.8.5. Mexico Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
  • 10.5.9. Argentina
    • 10.5.9.1. Overview
    • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.5.9.3. Argentina Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
    • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.9.5. Argentina Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
  • 10.5.10. Colombia
    • 10.5.10.1. Overview
    • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.5.10.3. Colombia Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
    • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.10.5. Colombia Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
  • 10.5.11. Rest of LATAM
    • 10.5.11.1. Overview
    • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
    • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
• 10.6. Middle East and Africa
  • 10.6.1. Overview
  • 10.6.2. Psychedelic Drugs Key Manufacturers in Middle East and Africa
  • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
  • 10.6.4. Middle East and Africa Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
  • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.6.6. Middle East and Africa Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
  • 10.6.7. Saudi Arabia
    • 10.6.7.1. Overview
    • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
    • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
  • 10.6.8. United Arab Emirates
    • 10.6.8.1. Overview
    • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
    • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
  • 10.6.9. Israel
    • 10.6.9.1. Overview
    • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.6.9.3. Israel Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
    • 10.6.9.4. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.9.5. Israel Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
  • 10.6.10. Turkey
    • 10.6.10.1. Overview
    • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.6.10.3. Turkey Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
    • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.10.5. Turkey Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
  • 10.6.11. Algeria
    • 10.6.11.1. Overview
    • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.6.11.3. Algeria Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
    • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.11.5. Algeria Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
  • 10.6.12. Egypt
    • 10.6.12.1. Overview
    • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.6.12.3. Egypt Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
    • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.12.5. Egypt Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
  • 10.6.13. Rest of MEA
    • 10.6.13.1. Overview
    • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.6.13.3. Rest of MEA Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
    • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.13.5. Rest of MEA Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Psychedelic Drugs Industry

• 11.1. Competitive Dashboard
• 11.2. Company Profiles
  • 11.2.1. Silo Wellness
  • 11.2.2. Revive Therapeutics
  • 11.2.3. PsyBio Therapeutics
  • 11.2.4. Numinus Wellness
  • 11.2.5. Mydecine Innovations Group
  • 11.2.6. MindMed
  • 11.2.7. MagicMed Industries
  • 11.2.8. Field Trip Health
  • 11.2.9. Entheon Biomedical
  • 11.2.10. Eleusis Ltd.
  • 11.2.11. Cybin Inc.
  • 11.2.12. Compass Pathways
  • 11.2.13. Bright Minds Biosciences
  • 11.2.14. Beckley Psytech
  • 11.2.15. Atai Life Sciences

12. 360 Degree Analyst View

13. Appendix

• 13.1. Research Methodology
• 13.2. References
• 13.3. Abbreviations
• 13.4. Disclaimer
• 13.5. Contact Us

관련자료